Navigation Links
Mylan Launches Generic Lipitor® in Five European Countries
Date:5/11/2012

PITTSBURGH and LYON, France, May 11, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has launched Atorvastatin Calcium Tablets, 10 mg, 20 mg, 40 mg and 80 mg in France, Belgium, the UK, the Netherlands and Ireland. Mylan has received marketing authorization from each country's respective health authority to begin selling its product immediately. Atorvastatin Calcium is the generic version of Pfizer's Lipitor® Tablets. This product is indicated for the prevention of cardiovascular disease and hypercholesterolemia.

Mylan CEO Heather Bresch said: "We are pleased to provide access to generic Lipitor to more than 4 million patients in five countries across Europe. Mylan is committed to expanding access to high quality medicine in Europe and around the world. Mylan's launch of Atorvastatin Calcium Tablets will help to provide health care systems in these markets with an estimated $700 million (euro 500 million) of savings in 2012 associated with the generic availability of this important medicine."

In France, Belgium, the UK, the Netherlands and Ireland, Lipitor had total sales of $1.6 billion (euro 1.126 billion) for the twelve months ending Dec. 31, 2011, according to IMS Health.

Mylan is a global pharmaceutical company committed to setting new standards in health care. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service a habit, do what's right, not what's easy and impact the future through passionate global leadership. We offer a growing portfolio of more than 1,100 generic pharmaceuticals and several brand medications. In addition, we offer a wide range of antiretroviral therapies, upon which approximately one-third of HIV/AIDS patients in developing countries depend. We also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in approximately 150 countries and territories. Our workforce of more than 18,000 people is dedicated to improving the customer experience and increasing pharmaceutical access to consumers around the world. But don't take our word for it. See for yourself. See inside. mylan.com


'/>"/>
SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
2. Mylan and Pfizer Announce Epinephrine Auto-injector Settlement Agreement with Teva
3. Mylan Launches Generic Version of Zyprexa® Tablets
4. Mylan Launches First Generic Version of Lescol® Capsules
5. Mylan Schedules First Quarter 2012 Financial Results Conference Call and Live Webcast
6. Mylan One of First to Launch Generic Version of Boniva®
7. Mylan Canada Receives Health Canada Approval for Generic Version of Crestor®
8. Mylan Continues to Pursue Damages and Injunction Against Sunovions Brovana® in Ongoing Litigation
9. Mylan Pharmaceuticals President Tony Mauro Elected Chairman of GPhA
10. Mylan Secures an Additional $300 Million of Committed Financing
11. Mylan Reports Adjusted Diluted EPS of $0.53 for the Quarter, an 18% Increase Over Prior Year Quarter; and $2.04 for the Year, a 27% Increase Over Prior Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2017)... 2017 A Catheterization Laboratory is an ... facility. Commonly referred to as cath lab, this ... imaging technology to give physicians visual access to ... spaces, a team of physicians perform life-saving procedures ... intervention, congenital heart defect closure, stenotic heart valves, ...
(Date:5/3/2017)... N.J. , May 3, 2017  Getinge, ... that contribute to quality enhancement and cost efficiency ... from a study of contemporary practice demonstrating that ... first-line therapy for critically ill patients. The single-center, ... Company,s newer large volume MEGA ® 50cc ...
(Date:5/2/2017)... and NEW YORK and ... -- As the leading distributor of market intelligence, MarketResearch.com ... European Med Tech Reimbursement Consulting AB that allows ... Reimbursement Consulting AB,s proprietary market analyses through the MarketResearch.com ... around the world easy access to complete product descriptions ...
Breaking Medicine Technology:
(Date:5/22/2017)... (PRWEB) , ... May 22, 2017 , ... ... part of a larger group investing in InsightRX, an early stage company in ... underlying biological and pharmacological characteristics. Greatpoint Ventures Innovation Fund acted as ...
(Date:5/21/2017)... ... May 20, 2017 , ... ... designs created specifically for use in Final Cut Pro X. The business-oriented elements ... productions. Pixel Film Studios’ ProParagraph Corporate will deliver a professional and distinguished look ...
(Date:5/21/2017)... , ... May 21, 2017 , ... For more than ... cover a wide range of knives and swords, from functional to fantasy. United Cutlery ... goods with sleek, modern designs that defy tradition. , Offering a range of weapons ...
(Date:5/19/2017)... ... May 19, 2017 , ... A leader in higher education ... began recruitment efforts for the inaugural cohort of its online Master of ... expertise to approach and address the unique nuances healthcare organizations face using a ...
(Date:5/19/2017)... ... May 19, 2017 , ... The Hill Agencies, a family managed firm that ... California Central Valley, is announcing a joint charity initiative with the Boys and Girls ... kid’s camp event. , The Boys and Girls Club of Kern County gives young ...
Breaking Medicine News(10 mins):